Lidocaine/tetracaine topical - Cutia Therapeutics
Alternative Names: CU-30101; Lidocaine/tetracaine cream - Cutia TherapeuticsLatest Information Update: 25 Apr 2023
At a glance
- Originator Cutia Therapeutics
- Class Acetanilides; Aminobenzoic acids; Local anaesthetics; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Anaesthesia
Most Recent Events
- 31 Mar 2023 Cutia Therapeutics plans a phase-III trial for Anaesthesia(Topical) in China (NCT05793892)
- 30 Nov 2022 Preclinical trials in Anaesthesia in China (Topical) (NCT05793892)
- 30 Nov 2022 Cutia Therapeutics announces intention to submit NDA to National Medical Products Administration for Anaesthesia (Topical) in 2025